SKINGENUITY Regenerative ICM (Inter-Cell Messenger Technology) GF Complex – Microneedling / Microchanneling Delivery Solution is a Powerful Serum that enhances the effect of existing procedures such as Micro Needling. ICM GF Complex – Micro Needling Solution will;
• Reduce the down time resulting from ablative and light based procedures by helping to reduce the redness associated with these treatments.
• Enhance the effect of the treatment by minimizing the long-term inflammation and ensuring that the right Growth Factors are delivered to improve the quality, texture, and strength of the skin.
• Work synergistically with SkinGenuity Skin Regenerative Serum and Accelerator.

Inter-Cell Messengers are the cornerstone of the SKINGENUITY technology. The Inter-Cell messengers are the “builders” of the body. Cells in the body die on a regular basis and Inter- Cell Messengers provide signals to the cells to replace and generate new cells.

What are Recombinant Growth Factors– And how are they made?

Recombinant growth factors are produced using CRISPR sequencing technology. Instead of extracting proteins from human stem cells, scientists encode microbiological cultures to produce specific growth factors. These cultures act as bio-factories, continuously generating high-purity proteins identical to those found in the human body.

This process is widely used in medical and cosmetic applications, ensuring both safety and efficacy. Recombinant technology has transformed the way bioactive compounds are produced, offering a controlled and highly precise alternative to traditional extraction methods.

For example, hyaluronic acid, a key ingredient in dermal fillers and much of skincare, was originally sourced from rooster combs. The process required significant purification and carried risks of variability… Today, hyaluronic acid is bioengineered using microbial fermentation, ensuring a pure, consistent, and animal-free product.

Another common human-derived protein produced through recombinant technology is insulin, which was once extracted from the pancreases of pigs and cows but is now synthesized using recombinant methods. By inserting the cellular code for human insulin into bacteria or yeast, scientists can produce an identical and highly purified version of insulin at scale, benefiting millions of people with diabetes worldwide.

The same principles apply recombinant growth factors. By utilizing advanced biotechnology, we can create growth factors with pinpoint accuracy—free from the natural variabilities and limitations of human derived stem cells.